MedTrace Logo

5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

NCT07480343 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-07-21

No results posted yet for this study

Summary

This study is designed to collect clinical data at 3, 4, and 5 years postoperatively for participants who completed the CREST Study without having secondary IOP-lowering surgery in the study eye(s).

Conditions

  • Open-angle Glaucoma (OAG)

Interventions

PROCEDURE

CycloPen Micro-Interventional Cyclodialysis System

The CycloPen Micro-Interventional Cyclodialysis System is used to create and cyclodialysis cleft and deliver allograft scleral tissue and/or viscous material to reinforce and maintain the cleft postoperatively.

PROCEDURE

CycloPen Micro-Interventional Cyclodialysis System Post Cataract

After cataract surgery, the CycloPen Micro-Interventional Cyclodialysis System is used to create and cyclodialysis cleft and deliver allograft scleral tissue and/or viscous material to reinforce and maintain the cleft postoperatively.

Sponsors & Collaborators

  • Iantrek, Inc.

    lead INDUSTRY

Principal Investigators

  • Tsontcho Ianchulev, MD, MPH · Iantrek, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-15
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07480343 on ClinicalTrials.gov